pamidronate has been researched along with Osteomyelitis in 41 studies
Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is the first randomized double-blinded, placebo-controlled pilot trial to investigate the efficacy of pamidronate in reducing radiological and clinical disease activity in chronic non-bacterial osteomyelitis (CNO)." | 9.34 | Pamidronate in chronic non-bacterial osteomyelitis: a randomized, double-blinded, placebo-controlled pilot trial. ( Andreasen, CM; Deleuran, BW; Folkmar, TB; Hauge, EM; Herlin, T; Horn, HC; Jurik, AG, 2020) |
| "The objectives were to assess changes in radiological disease activity in children with chronic non-bacterial osteomyelitis (CNO) receiving pamidronate therapy and to test a modified radiological index for non-bacterial osteitis (mRINBO) in CNO." | 8.12 | Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate. ( Andreasen, CM; Hauge, EM; Herlin, T; Jurik, AG; Klicman, RF, 2022) |
| "To evaluate patient-reported effectiveness, safety and social influence of Pamidronate in the therapy of NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis in children." | 8.12 | Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children. ( Juszczak, B; Sułko, J, 2022) |
| "The purpose of this study was (1) to assess the interreader reliability in detecting and scoring the inflammatory bone lesions in pediatric patients with chronic nonbacterial osteomyelitis (CNO) by using whole-body magnetic resonance imaging (WB-MRI), and (2) to evaluate the responsiveness of the MRI-detected CNO lesions to pamidronate therapy." | 8.02 | Whole-body MRI Quantification for Assessment of Bone Lesions in Chronic Nonbacterial Osteomyelitis Patients Treated With Pamidronate: A Prevalence, Reproducibility, and Responsiveness Study. ( Doria, AS; Laxer, RM; Lim, L; Panwar, J; Stimec, J; Tolend, M; Tse, SM, 2021) |
| "This study aimed to assess the clinical effectiveness of using pamidronate disodium to treat patients with diffuse sclerosing osteomyelitis of the mandible (DSOM )." | 7.96 | Application of pamidronate disodium for the treatment of diffuse sclerosing osteomyelitis of the mandible: A clinical study. ( An, J; Jia, K; Li, X; Zhang, Y, 2020) |
| "The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model." | 7.76 | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. ( Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A, 2010) |
| "There are only a few studies that address the frequency and type of spinal involvement in patients with chronic recurrent multifocal osteomyelitis (CRMO) as well as the outcome of these patients treated with pamidronate (PAM)." | 7.76 | Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. ( Dannecker, GE; Hospach, T; Langendoerfer, M; Maier, J; von Kalle, T, 2010) |
| "We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative." | 7.74 | Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. ( Ishikawa, M; Kitagawa, Y; Nomura, K; Notani, K; Satoh, C; Yamazaki, Y, 2007) |
| " Common step 2-3 treatments were pamidronate, methotrexate, and TNF-a-inhibition (anti-TNFα), the latter two regarded especially convenient to co-target extra-skeletal inflammation in SAPHO syndrome." | 4.31 | Diagnostic and therapeutic practices in adult chronic nonbacterial osteomyelitis (CNO). ( Appelman-Dijkstra, NM; Clunie, G; Dekkers, OM; Koutrouba, E; Leerling, AT; Winter, EM, 2023) |
| "The objectives were to assess changes in radiological disease activity in children with chronic non-bacterial osteomyelitis (CNO) receiving pamidronate therapy and to test a modified radiological index for non-bacterial osteitis (mRINBO) in CNO." | 4.12 | Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate. ( Andreasen, CM; Hauge, EM; Herlin, T; Jurik, AG; Klicman, RF, 2022) |
| "To evaluate patient-reported effectiveness, safety and social influence of Pamidronate in the therapy of NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis in children." | 4.12 | Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children. ( Juszczak, B; Sułko, J, 2022) |
| "The aim of this study was to evaluate a possible role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ) and to discuss an etiological model." | 3.76 | Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. ( Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A, 2010) |
| "There are only a few studies that address the frequency and type of spinal involvement in patients with chronic recurrent multifocal osteomyelitis (CRMO) as well as the outcome of these patients treated with pamidronate (PAM)." | 3.76 | Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. ( Dannecker, GE; Hospach, T; Langendoerfer, M; Maier, J; von Kalle, T, 2010) |
| "We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative." | 3.74 | Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. ( Ishikawa, M; Kitagawa, Y; Nomura, K; Notani, K; Satoh, C; Yamazaki, Y, 2007) |
| "Treatment with pamidronate provides both symptomatic relief as well as normalisation of bone morphology." | 1.51 | Treatment of chronic recurrent multifocal osteomyelitis with bisphosphonates in children. ( Bień, S; Błażkiewicz, M; Ebisz, M; Jurczyk, M; Namyślak, M; Sułko, J, 2019) |
| "CRMO associated with ulcerative colitis (UC) is very rarely reported." | 1.39 | Sternocostal involvement in chronic recurrent multifocal osteomyelitis associated with ulcerative colitis. ( Kim, HS; Kim, YS; Lee, J, 2013) |
| "Pamidronate was administered intravenously up to four times a year." | 1.37 | Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. ( de Jong, E; Hamdy, NA; Kuijpers, SC; van Merkesteyn, JP, 2011) |
| "Five patients with CRMO, all of whom had ongoing pain and loss of function despite conventional treatment with non-steroidal anti-inflammatory agents, were treated with pamidronate (1 mg/kg/dose with a dosing frequency of 2 to 4 monthly for a total treatment duration of 12 to 42 months)." | 1.35 | Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. ( Allen, RC; Simm, PJ; Zacharin, MR, 2008) |
| "Recent cases of bone necrosis of the jaws have been associated with the use of bisphosphonate therapy." | 1.35 | Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management. ( Fayans, EP; Grewal, VS, 2008) |
| "Calcaneal osteomyelitis is uncommon and difficult to treat." | 1.33 | Calcaneal osteomyelitis due to fistulization of an ulcerated rheumatoid nodule. ( Alcaraz, P; Announ, N; Aubran, C; Chagnaud, C; Guis, S; Jaoua, S; Mattei, JP; Roudier, C; Roudier, J, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (34.15) | 29.6817 |
| 2010's | 16 (39.02) | 24.3611 |
| 2020's | 11 (26.83) | 2.80 |
| Authors | Studies |
|---|---|
| Schnabel, A | 1 |
| Nashawi, M | 1 |
| Anderson, C | 1 |
| Felsenstein, S | 1 |
| Lamoudi, M | 1 |
| Poole-Cowley, J | 1 |
| Lindell, E | 1 |
| Oates, B | 1 |
| Fowlie, P | 1 |
| Walsh, J | 1 |
| Ellis, T | 1 |
| Hahn, G | 1 |
| Goldspink, A | 1 |
| Martin, N | 1 |
| Mahmood, K | 1 |
| Hospach, T | 2 |
| Lj, M | 1 |
| Hedrich, CM | 2 |
| Andreasen, CM | 3 |
| Klicman, RF | 1 |
| Herlin, T | 4 |
| Hauge, EM | 3 |
| Jurik, AG | 3 |
| Fraleigh, R | 1 |
| Wei, XC | 1 |
| Yu, W | 1 |
| Miettunen, PM | 1 |
| Stojkic, I | 1 |
| Rubin, E | 1 |
| Lee, J | 2 |
| Lee, ASE | 1 |
| Ogbu, EA | 1 |
| Leerling, AT | 1 |
| Clunie, G | 1 |
| Koutrouba, E | 1 |
| Dekkers, OM | 1 |
| Appelman-Dijkstra, NM | 1 |
| Winter, EM | 1 |
| Gaal, A | 1 |
| Basiaga, ML | 1 |
| Zhao, Y | 1 |
| Egbert, M | 1 |
| Kaneko, S | 1 |
| Shimizu, M | 1 |
| Inoue, N | 1 |
| Mizuta, M | 1 |
| Yachie, A | 1 |
| Deleuran, BW | 1 |
| Horn, HC | 1 |
| Folkmar, TB | 1 |
| Li, X | 1 |
| Jia, K | 1 |
| An, J | 1 |
| Zhang, Y | 1 |
| Panwar, J | 1 |
| Tolend, M | 1 |
| Lim, L | 1 |
| Tse, SM | 1 |
| Doria, AS | 1 |
| Laxer, RM | 2 |
| Stimec, J | 1 |
| Juszczak, B | 1 |
| Sułko, J | 2 |
| Tronconi, E | 1 |
| Miniaci, A | 1 |
| Baldazzi, M | 1 |
| Greco, L | 1 |
| Pession, A | 1 |
| Kostik, MM | 1 |
| Kopchak, OL | 1 |
| Chikova, IA | 1 |
| Isupova, EA | 1 |
| Mushkin, AY | 1 |
| Glerup, MB | 1 |
| Høst, C | 1 |
| Mahler, BT | 1 |
| Ramanan, AV | 2 |
| Hampson, LV | 1 |
| Lythgoe, H | 1 |
| Jones, AP | 1 |
| Hardwick, B | 1 |
| Hind, H | 1 |
| Jacobs, B | 1 |
| Vasileiou, D | 1 |
| Wadsworth, I | 1 |
| Ambrose, N | 1 |
| Davidson, J | 1 |
| Ferguson, PJ | 2 |
| Kavirayani, A | 1 |
| Killeen, OG | 1 |
| Compeyrot-Lacassagne, S | 1 |
| Roderick, M | 1 |
| Swart, JF | 1 |
| Beresford, MW | 1 |
| Ebisz, M | 1 |
| Bień, S | 1 |
| Błażkiewicz, M | 1 |
| Jurczyk, M | 1 |
| Namyślak, M | 1 |
| Handly, B | 1 |
| Moore, M | 1 |
| Creutzberg, G | 1 |
| Groh, B | 1 |
| Mosher, T | 1 |
| Rao, AP | 1 |
| Gopalakrishna, DB | 1 |
| Bing, X | 1 |
| Roderick, MR | 1 |
| Shah, R | 1 |
| Rogers, V | 1 |
| Finn, A | 1 |
| Alons, K | 1 |
| Kuijpers, SC | 2 |
| de Jong, E | 2 |
| van Merkesteyn, JP | 2 |
| Hoefert, S | 1 |
| Schmitz, I | 1 |
| Tannapfel, A | 1 |
| Eufinger, H | 1 |
| Langendoerfer, M | 1 |
| von Kalle, T | 1 |
| Maier, J | 1 |
| Dannecker, GE | 1 |
| Hamdy, NA | 1 |
| Conejo-Fernández, A | 1 |
| Núñez Cuadros, E | 1 |
| Jiménez Hinojosa, JM | 1 |
| Urda Cardona, AL | 1 |
| Bartl, R | 1 |
| Jacobsen, C | 1 |
| Metzler, P | 1 |
| Rössle, M | 1 |
| Obwegeser, J | 1 |
| Zemann, W | 1 |
| Grätz, KW | 1 |
| Urade, M | 1 |
| Noguchi, K | 1 |
| Takaoka, K | 1 |
| Moridera, K | 1 |
| Kishimoto, H | 1 |
| Kim, YS | 1 |
| Kim, HS | 1 |
| Sugata, T | 1 |
| Fujita, Y | 1 |
| Myoken, Y | 1 |
| Kiriyama, T | 1 |
| Tanvetyanon, T | 1 |
| Alcaraz, P | 1 |
| Aubran, C | 1 |
| Jaoua, S | 1 |
| Roudier, C | 1 |
| Mattei, JP | 1 |
| Announ, N | 1 |
| Chagnaud, C | 1 |
| Roudier, J | 1 |
| Guis, S | 1 |
| Zarychanski, R | 1 |
| Elphee, E | 1 |
| Walton, P | 1 |
| Johnston, J | 1 |
| Thakkar, SG | 1 |
| Isada, C | 1 |
| Smith, J | 1 |
| Karam, MA | 1 |
| Reed, J | 1 |
| Tomford, JW | 1 |
| Englund, K | 1 |
| Richmond, M | 1 |
| Licata, A | 1 |
| Hatch, C | 1 |
| Hussein, MA | 1 |
| Weeda, LW | 1 |
| Yamazaki, Y | 1 |
| Satoh, C | 1 |
| Ishikawa, M | 1 |
| Notani, K | 1 |
| Nomura, K | 1 |
| Kitagawa, Y | 1 |
| Sanna, G | 1 |
| Preda, L | 1 |
| Bruschini, R | 1 |
| Cossu Rocca, M | 1 |
| Verri, E | 1 |
| Bellomi, M | 1 |
| Goldhirsch, A | 1 |
| Nole, F | 1 |
| Simm, PJ | 1 |
| Allen, RC | 1 |
| Zacharin, MR | 1 |
| Gleeson, H | 1 |
| Wiltshire, E | 1 |
| Briody, J | 1 |
| Hall, J | 1 |
| Chaitow, J | 1 |
| Sillence, D | 1 |
| Cowell, C | 1 |
| Munns, C | 1 |
| Grewal, VS | 1 |
| Fayans, EP | 1 |
| Coinde, E | 1 |
| David, L | 1 |
| Cottalorda, J | 1 |
| Allard, D | 1 |
| Bost, M | 1 |
| Lucht, F | 1 |
| Stéphan, JL | 1 |
| Soubrier, M | 1 |
| Dubost, JJ | 1 |
| Ristori, JM | 1 |
| Sauvezie, B | 1 |
| Bussière, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chronic Non-bacterial Osteomyelitis Treated With Pamidronate in a Randomised Placebo Controlled Trial[NCT02594878] | Phase 2 | 32 participants (Anticipated) | Interventional | 2015-10-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for pamidronate and Osteomyelitis
| Article | Year |
|---|---|
Chronic recurrent multifocal osteomyelitis with myositis: A case report and review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Chronic Disease; C | 2020 |
Biologic treatment for chronic recurrent multifocal osteomyelitis: report of four cases and review of the literature.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Bone and Bones; Child; Dip | 2018 |
1 trial available for pamidronate and Osteomyelitis
| Article | Year |
|---|---|
Pamidronate in chronic non-bacterial osteomyelitis: a randomized, double-blinded, placebo-controlled pilot trial.
Topics: Adult; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Double-Blind Method; Female; H | 2020 |
38 other studies available for pamidronate and Osteomyelitis
| Article | Year |
|---|---|
TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter study.
Topics: Diphosphonates; Female; Humans; Osteomyelitis; Pamidronate; Retrospective Studies; Treatment Outcome | 2022 |
Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate.
Topics: Child; Chronic Disease; Female; Humans; Magnetic Resonance Imaging; Male; Osteitis; Osteomyelitis; P | 2022 |
Chronic recurrent multifocal osteomyelitis with a comprehensive approach to differential diagnosis of paediatric skull pain.
Topics: Child; Chronic Disease; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Osteiti | 2023 |
An unusual presentation of chronic recurrent multifocal osteomyelitis involving bones of the skull.
Topics: Adolescent; Child; Chronic Disease; Diagnostic Imaging; Humans; Male; Osteomyelitis; Pamidronate; Re | 2023 |
Diagnostic and therapeutic practices in adult chronic nonbacterial osteomyelitis (CNO).
Topics: Acquired Hyperostosis Syndrome; Adult; Child; Humans; Hyperostosis; Inflammation; Osteitis; Osteomye | 2023 |
Pediatric chronic nonbacterial osteomyelitis of the mandible: Seattle Children's hospital 22-patient experience.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Humans; Magnetic Resonance Imaging; Male; Ma | 2020 |
Application of pamidronate disodium for the treatment of diffuse sclerosing osteomyelitis of the mandible: A clinical study.
Topics: China; Diphosphonates; Humans; Mandible; Osteomyelitis; Pamidronate | 2020 |
Whole-body MRI Quantification for Assessment of Bone Lesions in Chronic Nonbacterial Osteomyelitis Patients Treated With Pamidronate: A Prevalence, Reproducibility, and Responsiveness Study.
Topics: Child; Humans; Magnetic Resonance Imaging; Osteomyelitis; Pamidronate; Prevalence; Reproducibility o | 2021 |
Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Chronic Disease; Drug-Related Side Effects and Adver | 2022 |
Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Child, | 2019 |
Response to Early-onset Pamidronate Treatment in Chronic Nonbacterial Osteomyelitis: A Retrospective Single-center Study.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Denmar | 2019 |
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.
Topics: Adalimumab; Bayes Theorem; Consensus; Female; Humans; Male; Osteomyelitis; Pain Management; Pamidron | 2019 |
Treatment of chronic recurrent multifocal osteomyelitis with bisphosphonates in children.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Cohort Studies; Diphosphonates; Dose-Res | 2019 |
Bisphosphonate therapy for chronic recurrent multifocal osteomyelitis.
Topics: Adolescent; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Humans; Male; Osteomy | 2013 |
Phenotypic Variability in Majeed Syndrome.
Topics: Adolescent; Anemia, Dyserythropoietic, Congenital; Arthritis, Juvenile; Diphosphonates; Follow-Up St | 2016 |
Chronic recurrent multifocal osteomyelitis (CRMO) - advancing the diagnosis.
Topics: Adolescent; Anti-Bacterial Agents; Arthritis, Juvenile; Biopsy; Bone Density Conservation Agents; Bo | 2016 |
Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Chronic | 2009 |
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Di | 2010 |
Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate.
Topics: Adolescent; Back Pain; Bone Density Conservation Agents; Child; Chronic Disease; Diphosphonates; Fem | 2010 |
Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates.
Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Child; Diphosphonates; Female; Follow-Up | 2011 |
[Pamidronate: a therapeutic alternative in chronic recurrent mutifocal osteomyelitis].
Topics: Child; Chronic Disease; Diphosphonates; Female; Humans; Osteomyelitis; Pamidronate; Recurrence | 2011 |
[Inflammation of the jaws during treatment with bisphosphonates].
Topics: Administration, Oral; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseas | 2011 |
Osteopathology induced by bisphosphonates and dental implants: clinical observations.
Topics: Actinomycosis; Administration, Intravenous; Administration, Oral; Alendronate; Anti-Bacterial Agents | 2013 |
Diffuse sclerosing osteomyelitis of the mandible successfully treated with pamidronate: a long-term follow-up report.
Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Mandibular Diseases; Middle Aged; | 2012 |
Sternocostal involvement in chronic recurrent multifocal osteomyelitis associated with ulcerative colitis.
Topics: Adult; Bone Density Conservation Agents; Colitis, Ulcerative; Diphosphonates; Drug Therapy, Combinat | 2013 |
Successful management of severe facial pain in patients with diffuse sclerosing osteomyelitis (DSO) of the mandible using disodium clodronate.
Topics: Anti-Inflammatory Agents; Diphosphonates; Facial Pain; Female; Humans; Mandibular Diseases; Middle A | 2003 |
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazol | 2005 |
Calcaneal osteomyelitis due to fistulization of an ulcerated rheumatoid nodule.
Topics: Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Calcaneus; Cutaneous Fistula; Diphosp | 2006 |
Osteonecrosis of the jaw associated with pamidronate therapy.
Topics: Actinomycosis; Antineoplastic Agents; Diphosphonates; Female; Humans; Male; Mandible; Neoplasms; Ost | 2006 |
Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.
Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Midd | 2006 |
Drug induced osteonecrosis of the jaws.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density; Bone Densit | 2006 |
Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate.
Topics: Bone Density Conservation Agents; Child; Chronic Disease; Diphosphonates; Humans; Male; Mandibular D | 2007 |
The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates.
Topics: Adenocarcinoma; Bone Neoplasms; Bone Plates; Bone Screws; Breast Neoplasms; Cutaneous Fistula; Dipho | 2008 |
Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis.
Topics: Adolescent; Child; Chronic Disease; Diphosphonates; Female; Humans; Male; Osteomyelitis; Pamidronate | 2008 |
Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape.
Topics: Adolescent; Anti-Inflammatory Agents; Bone Density; Child; Child, Preschool; Diphosphonates; Female; | 2008 |
Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Density Conservation Ag | 2008 |
[Chronic recurrent multifocal osteomyelitis in children: report of 17 cases].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Bone and Bones; Child; Child, Pr | 2001 |
Pamidronate in the treatment of diffuse sclerosing osteomyelitis of the mandible.
Topics: Aged; Anti-Inflammatory Agents; Diphosphonates; Female; Humans; Mandibular Diseases; Osteomyelitis; | 2001 |